| TOB1 |
TOB1, TOB, TROB1: Protein Tob1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
5.505 |
Evidence |
O
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
PPP1R14A |
PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A |
5.505 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
5.505 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| ARID4A |
ARID4A, RBBP1, RBP1: AT-rich interactive domain-containing protein 4A |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
5.505 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
PHC3 |
PHC3, EDR3, PH3: Polyhomeotic-like protein 3 |
5.505 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
PHC3 |
PHC3, EDR3, PH3: Polyhomeotic-like protein 3 |
5.505 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
PHC3 |
PHC3, EDR3, PH3: Polyhomeotic-like protein 3 |
5.505 |
Evidence |
|
| YY1 |
YY1: Transcriptional repressor protein YY1 |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
5.505 |
Evidence |
|
| RPS6KB1 |
IPI00216132 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
5.505 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
RBM15B |
RBM15B: Putative RNA-binding protein 15B |
5.505 |
Evidence |
|
| PTPRF |
PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
O
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| TH |
TH, TYH: Tyrosine 3-monooxygenase |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
5.505 |
Evidence |
|
| TH |
TH, TYH: Tyrosine 3-monooxygenase |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
5.505 |
Evidence |
|